Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Oncol Rep ; 50(1)2023 Jul.
Article in English | MEDLINE | ID: mdl-37232374

ABSTRACT

Breast cancer is one of the major causes of cancer­related mortality among women worldwide. It metastasizes to distant organs, particularly to bone tissue. Nitrogen­containing bisphosphonates are mainly used as an adjuvant therapy to inhibit skeletal­related events; however, there is increasing evidence to suggest that these compounds also exert antitumor effects. In previous studies, the authors synthesized two novel aminomethylidenebisphosphonates (BPs), namely benzene­1,4­bis[aminomethylidene(bisphosphonic)] acid (WG12399C) and naphthalene­1,5­bis[aminomethylidene(bisphosphonic)] acid (WG12592A). Both BPs exhibited notable antiresorptive activity in a mouse model of osteoporosis. The present study aimed to assess the in vivo anticancer activity of WG12399C and WG12592A in 4T1 breast adenocarcinoma model. WG12399C exerted an anti­metastatic effect by reducing the number of spontaneous lung metastases by ~66% in comparison to the control. In the experimental metastasis model of 4T1­luc2­tdTomato cells, this compound reduced the incidence of tumor metastases in the lungs by approximately half in comparison to the control. Both WG12399C and WG12595A also significantly reduced the size and/or number of bone metastatic foci. Their pro­apoptotic and anti­proliferative activity may, at least in part, explain the observed effects. Incubation with WG12399C induced an almost 6­fold increase in caspase­3 activity in 4T1 cells. Moreover, cells treated with WG12399C or WG12595A exhibited a 2­fold reduction in invasiveness through Matrigel. Furthermore, both the BPs were able to sensitize the 4T1 cells to cytostatics. In summary, the results of the present study indicate that the examined aminomethylidene­BPs may be of particular interest in the context of combined treatment in breast cancer therapy.


Subject(s)
Bone Neoplasms , Lung Neoplasms , Animals , Mice , Female , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Diphosphonates/pharmacology , Lung Neoplasms/secondary , Cell Line, Tumor , Mice, Inbred BALB C
2.
J Vis Exp ; (186)2022 08 04.
Article in English | MEDLINE | ID: mdl-35993740

ABSTRACT

Cell populations that have stable changes in their genomic information are widely used by scientists as a research model. They do not require repeated cell transfection as it can lead to a heterogeneous cell population and variable transfection efficiency, affecting reproducibility. Moreover, they are preferable for large-scale analyses. The generation of stable cell clones is useful for a wide range of applications, such as research on gene functions and recombinant protein production. There are a few methods to obtain a homogenous cell population upon initial transient transfection. Here, we describe the isolation of single cell clones with glass cylinders. Although this method has been known for some time, there are a few crucial steps, and neglecting them may lead to failure. We have successfully used this method to obtain clones stably overexpressing a protein of interest (POI) or with knockout of a gene of interest (GOI). We describe preparation steps such as the optimization of selecting drug concentrations, preparation of glass cylinders, and validation of whether the obtained clones have the desired change in the expression of the GOI by PCR, western blot analysis, immunostaining, or gDNA sequencing (depending on the type of derived clones). We also discuss the phenotypic heterogeneity of well-established cell lines as this might be an issue in obtaining stable cell clones.


Subject(s)
Melanoma , Clone Cells , Humans , Melanoma/genetics , Recombinant Proteins/metabolism , Reproducibility of Results , Transfection
3.
J Vis Exp ; (181)2022 03 09.
Article in English | MEDLINE | ID: mdl-35343958

ABSTRACT

Melanoma cells, having highly invasive properties, exhibit the formation of invadopodia-structures formed by tumor cells and responsible for the digestion of the surrounding extracellular matrix (ECM). Several metalloproteases (MMPs) are secreted by cells to hydrolyze ECM proteins. They are mainly secreted through structures known as invadopodia. ECM degradation is crucial for tumor cells while forming metastases as the cells heading towards blood vessels must loosen dense tissue. One group of metalloproteases secreted by melanoma cells comprises the gelatinases, i.e., metalloproteases 2 and 9. Gelatinases cleave gelatin (denatured collagen), a few types of collagen (including type IV), and fibronectin, all structural components of ECM. This paper describes a gelatin zymography assay to analyze the gelatinase activity of melanoma cells. This approach is based on analyzing the extent of digestion of a substrate (gelatin) added to a polyacrylamide gel. Several advantages, such as simplicity, sensitivity, low cost, and semiquantitative analysis by densitometry, as well as the detection of both active and inactive forms of MMPs, make this assay valuable and widely used. This protocol describes how to concentrate medium devoid of intact floating cells, cell debris, and apoptotic bodies. Next, it focuses on preparing polyacrylamide gel with gelatin addition, performing sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE), removing SDS, and staining of the gel to detect gelatin-free bands corresponding to the activity of gelatinases secreted by melanoma cells. Finally, the paper describes how to quantitatively analyze data from this assay. This method is a good alternative for estimating the gelatinase activity of melanoma cells to a fluorescent gelatin degradation assay, western blot, or enzyme-linked immunosorbent assays (ELISAs).


Subject(s)
Gelatinases , Melanoma , Electrophoresis, Polyacrylamide Gel , Extracellular Matrix/metabolism , Gelatin/metabolism , Gelatinases/analysis , Gelatinases/metabolism , Humans , Melanoma/pathology
4.
Cells ; 10(7)2021 07 02.
Article in English | MEDLINE | ID: mdl-34359835

ABSTRACT

Integrin-linked kinase (ILK) is mainly localized in focal adhesions where it interacts and modulates the downstream signaling of integrins affecting cell migration, adhesion, and survival. The interaction of dorsal root ganglia (DRG) cells, being part of the peripheral nervous system (PNS), with the extracellular matrix (ECM) via integrins is crucial for proper PNS development. A few studies have focused on ILK's role in PNS development, but none of these have focused on chicken. Therefore, we decided to investigate ILK's role in the development of Gallus gallus domesticus's DRG. First, using RT-PCR, Western blotting, and in situ hybridization, we show that ILK is expressed in DRG. Next, by immunocytochemistry, we show ILK's localization both intracellularly and on the cell membrane of DRG neurons and Schwann cell precursors (SCPs). Finally, we describe ILK's involvement in multiple aspects of DRG development by performing functional experiments in vitro. IgG-mediated interruption of ILK's action improved DRG neurite outgrowth, modulated their directionality, stimulated SCPs migration, and impacted growth cone morphology in the presence of laminin-1 or laminin-1 mimicking peptide IKVAV. Taken together, our results show that ILK is important for chicken PNS development, probably via its exposure to the ECM.


Subject(s)
Avian Proteins/genetics , Chickens/genetics , Embryonic Development/genetics , Ganglia, Spinal/metabolism , Laminin/genetics , Protein Serine-Threonine Kinases/genetics , Amino Acid Sequence , Animals , Avian Proteins/metabolism , Cell Adhesion , Cell Membrane/chemistry , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Movement , Cell Survival , Chickens/growth & development , Chickens/metabolism , Embryo, Nonmammalian , Extracellular Matrix/chemistry , Extracellular Matrix/metabolism , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Ganglia, Spinal/growth & development , Gene Expression Regulation, Developmental , Laminin/metabolism , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Peptides/chemical synthesis , Peptides/pharmacology , Protein Serine-Threonine Kinases/metabolism , Schwann Cells/cytology , Schwann Cells/drug effects , Schwann Cells/metabolism
5.
Cells ; 10(8)2021 07 21.
Article in English | MEDLINE | ID: mdl-34440617

ABSTRACT

Skin melanocytes reside on the basement membrane (BM), which is mainly composed of laminin, collagen type IV, and proteoglycans. For melanoma cells, in order to invade into the skin, melanocytes must cross the BM. It has been reported that changes in the composition of the BM accompany melanocytes tumorigenesis. Previously, we reported high gelsolin (GSN)-an actin-binding protein-levels in melanoma cell lines and GSN's importance for migration of A375 cells. Here we investigate whether melanoma cells migrate differently depending on the type of fibrous extracellular matrix protein. We obtained A375 melanoma cells deprived of GSN synthesis and tested their migratory properties on laminin, collagens type I and IV, fibronectin, and Matrigel, which resembles the skin's BM. We applied confocal and structured illuminated microscopy (SIM), gelatin degradation, and diverse motility assays to assess GSN's influence on parameters associated with cells' ability to protrude. We show that GSN is important for melanoma cell migration, predominantly on laminin, which is one of the main components of the skin's BM.


Subject(s)
Basement Membrane/metabolism , Cell Movement , Extracellular Matrix/metabolism , Gelsolin/metabolism , Melanoma/metabolism , Skin Neoplasms/metabolism , Tumor Microenvironment , Basement Membrane/pathology , Collagen Type I/metabolism , Collagen Type IV/metabolism , Extracellular Matrix/pathology , Fibronectins/metabolism , Gelsolin/genetics , Humans , Laminin/metabolism , Melanoma/genetics , Melanoma/pathology , Neoplasm Invasiveness , Podosomes/metabolism , Podosomes/pathology , Signal Transduction , Skin Neoplasms/genetics , Skin Neoplasms/pathology
6.
Cells ; 10(4)2021 03 31.
Article in English | MEDLINE | ID: mdl-33807338

ABSTRACT

Thymosin ß4 (Tß4) is a small, 44-amino acid polypeptide. It has been implicated in multiple processes, including cell movement, angiogenesis, and stemness. Previously, we reported that melanoma cell lines differ in Tß4 levels. Studies on stable clones with silenced TMSB4X expression showed that Tß4 impacted adhesion and epithelial-mesenchymal transition progression. Here, we show that the cells with silenced TMSB4X expression exhibited altered actin cytoskeleton's organization and subcellular relocalization of two intermediate filament proteins: Nestin and Vimentin. The rearrangement of the cell cytoskeleton resulted in changes in the cells' topology, height, and stiffness defined by Young's modulus. Simultaneously, only for some A375 clones with a lowered Tß4 level, we observed a decreased ability to initiate colony formation in soft agar, tumor formation in vivo, and alterations in Nanog's expression level transcription factor regulating stemness. Thus, we show for the first time that in A375 cells, biomechanical properties are not directly coupled to stemness features, and this cell line is phenotypically heterogeneous.


Subject(s)
Gene Silencing , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Thymosin/metabolism , Actin Cytoskeleton/metabolism , Biomarkers, Tumor/metabolism , Biomechanical Phenomena , Carcinogenesis/pathology , Cell Cycle , Cell Line, Tumor , Cell Proliferation , Cell Shape , Humans , Intermediate Filaments/metabolism , Melanoma/pathology , Models, Biological , Nestin/metabolism , Vimentin/metabolism
7.
Methods Mol Biol ; 2265: 47-63, 2021.
Article in English | MEDLINE | ID: mdl-33704704

ABSTRACT

In order to protrude within a dense tissue, tumor cells have to develop the ability to digest the extracellular matrix (ECM). Melanoma cells, similarly to other types of tumor cells, form invadopodia, membranous invaginations rich in filamentous actin and several other proteins including matrix metalloproteinases (MMPs). MMPs degrade ECM structural proteins such as collagens, fibronectin, or laminin. Here we describe an assay that allows the detection of gelatinase activity exhibited by tumor cells under 2D conditions and methods to present obtained data in both a quantitative and a qualitative manner.


Subject(s)
Extracellular Matrix/enzymology , Gelatin/metabolism , Melanoma/enzymology , Microscopy, Confocal/methods , Actins/metabolism , Cell Culture Techniques/methods , Cell Line, Tumor , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Fluorescence , Gelatinases/metabolism , Humans , Matrix Metalloproteinases/metabolism , Melanoma/pathology , Optical Imaging , Podosomes/enzymology , Podosomes/metabolism , Podosomes/pathology
8.
Sci Rep ; 11(1): 3329, 2021 02 08.
Article in English | MEDLINE | ID: mdl-33558623

ABSTRACT

We have recently found that ß-actin-like protein 2 (actbl2) forms complexes with gelsolin in human melanoma cells and can polymerize. Phylogenetic and bioinformatic analyses showed that actbl2 has a common origin with two non-muscle actins, which share a separate history from the muscle actins. The actin groups' divergence started at the beginning of vertebrate evolution, and actbl2 actins are characterized by the largest number of non-conserved amino acid substitutions of all actins. We also discovered that ACTBL2 is expressed at a very low level in several melanoma cell lines, but a small subset of cells exhibited a high ACTBL2 expression. We found that clones with knocked-out ACTBL2 (CR-ACTBL2) or overexpressing actbl2 (OE-ACTBL2) differ from control cells in the invasion, focal adhesion formation, and actin polymerization ratio, as well as in the formation of lamellipodia and stress fibers. Thus, we postulate that actbl2 is the seventh actin isoform and is essential for cell motility.


Subject(s)
Cell Movement , Focal Adhesions/metabolism , Gene Expression Regulation, Neoplastic , Melanoma/metabolism , Neoplasm Proteins/biosynthesis , Retroelements , Cell Line, Tumor , Focal Adhesions/genetics , Focal Adhesions/pathology , Humans , Melanoma/genetics , Melanoma/pathology , Neoplasm Invasiveness , Neoplasm Proteins/genetics
9.
Int J Mol Sci ; 21(8)2020 Apr 15.
Article in English | MEDLINE | ID: mdl-32326615

ABSTRACT

Non-muscle actins have been studied for many decades; however, the reason for the existence of both isoforms is still unclear. Here we show, for the first time, a successful inactivation of the ACTB (CRISPR clones with inactivated ACTB, CR-ACTB) and ACTG1 (CRISPR clones with inactivated ACTG1, CR-ACTG1) genes in human melanoma cells (A375) via the RNA-guided D10A mutated Cas9 nuclease gene editing [CRISPR/Cas9(D10A)] technique. This approach allowed us to evaluate how melanoma cell motility was impacted by the lack of either ß actin coded by ACTB or γ actin coded by ACTG1. First, we observed different distributions of ß and γ actin in the cells, and the absence of one actin isoform was compensated for via increased expression of the other isoform. Moreover, we noted that γ actin knockout had more severe consequences on cell migration and invasion than ß actin knockout. Next, we observed that the formation rate of bundled stress fibers in CR-ACTG1 cells was increased, but lamellipodial activity in these cells was impaired, compared to controls. Finally, we discovered that the formation rate of focal adhesions (FAs) and, subsequently, FA-dependent signaling were altered in both the CR-ACTB and CR-ACTG1 clones; however, a more detrimental effect was observed for γ actin-deficient cells. Our research shows that both non-muscle actins play distinctive roles in melanoma cells' FA formation and motility.


Subject(s)
Actins/metabolism , CRISPR-Cas Systems , Focal Adhesions/metabolism , Gene Editing/methods , Gene Knockout Techniques/methods , Melanoma/metabolism , Actins/analysis , Actins/genetics , Cell Line, Tumor , Cell Movement/drug effects , Cell Movement/genetics , Focal Adhesions/drug effects , Focal Adhesions/genetics , Humans , Lysophospholipids/pharmacology , Melanoma/genetics , Neoplasm Invasiveness/genetics , Protein Isoforms/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Stress Fibers/genetics , Stress Fibers/metabolism , Tetradecanoylphorbol Acetate/analogs & derivatives , Tetradecanoylphorbol Acetate/pharmacology
10.
Chem Biol Drug Des ; 94(4): 1835-1848, 2019 10.
Article in English | MEDLINE | ID: mdl-31356729

ABSTRACT

Nitrogen-containing bisphosphonates (N-BPs) inhibit bone resorption by preventing osteoclast activity. Most clinically used BPs are hydroxybisphosphonates with the exception of incadronate, which belongs to the class of aminomethylidenebisphosphonic acids. The aim of this study was to evaluate the antiproliferative activity of two previously reported aminobisphosphonates (WG8185B2 and WG9001B) in combination with doxorubicin and cisplatin toward J774E cells (a model of osteoclast precursors in vitro). WG8185B2 and WG9001B BPs enhanced the cytotoxic activity of doxorubicin and cisplatin, especially when applied 24 hr prior to cytostatics. The antiproliferative effect of studied BPs was related to the changes in cell cycle progression. WG8185B2 leads to significant accumulation of J774E cells in S phase, whereas WG9001B causes transient arrest in G2 /M phase, followed by an increase in the percentage of cells in S phase. Moreover, WG8185B2 and WG9001B BPs showed enhanced proapoptotic activity in osteoclast precursors, which was manifested by an increase in caspase-3 activity and percentage of apoptotic cells. In addition, both compounds influenced the motility of J774E cells. The exact molecular mechanism of action of examined BPs remains to be determined; however, results show an interesting biological activity of these compounds, which may be of interest in the context of antiresorptive therapy.


Subject(s)
Apoptosis/drug effects , Diphosphonates , G2 Phase Cell Cycle Checkpoints/drug effects , M Phase Cell Cycle Checkpoints/drug effects , Osteoclasts/metabolism , S Phase/drug effects , Animals , Bone Resorption/drug therapy , Bone Resorption/metabolism , Bone Resorption/pathology , Caspase 3/metabolism , Cell Line , Cisplatin/pharmacology , Diphosphonates/chemical synthesis , Diphosphonates/chemistry , Diphosphonates/pharmacology , Doxorubicin/pharmacology , Mice , Osteoclasts/pathology
11.
Front Cell Dev Biol ; 7: 304, 2019.
Article in English | MEDLINE | ID: mdl-31921836

ABSTRACT

Thymosin ß4 (Tß4), a multifunctional 44-amino acid polypeptide and a member of actin-binding proteins (ABPs), plays an important role in developmental processes and wound healing. In recent years an increasing number of data has been published suggesting Tß4's involvement in tumorigenesis. However, Tß4's role in melanoma tumor development still remains to be elucidated. In our study we demonstrate that Tß4 is crucial for melanoma adhesion and invasion. For the purpose of our research we tested melanoma cell lines differing in invasive potential. Moreover, we applied shRNAs to silence TMSB4X (gene encoding Tß4) expression in a cell line with high TMSB4X expression. We found out that Tß4 is not only a component of focal adhesions (FAs) and interacts with several FAs components but also regulates FAs formation. We demonstrate that Tß4 level has an impact on FAs' number and morphology. Moreover, manipulation with TMSB4X expression resulted in changes in cells' motility on non-coated and MatrigelTM (resembling basement membrane composition)-coated surfaces and drastically decreased invasion abilities of the cells. Additionally, a correlation between Tß4 expression level and exhibition of mesenchymal-like [epithelial-mesenchymal transition (EMT)] features was discovered. Cells with lowered TMSB4X expression were less EMT-progressed than control cells. Summarizing, obtained results show that Tß4 by regulating melanoma cells' adhesion has an impact on motility features and EMT. Our study not only contributes to a better understanding of the processes underlying melanoma cells' capacity to create metastases but also highlights Tß4 as a potential target for melanoma management therapy.

SELECTION OF CITATIONS
SEARCH DETAIL
...